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EVIDENCE-BASED DIAGNOSTICS

Spontaneous Subarachnoid Hemorrhage:
A Systematic Review and Meta-analysis
Describing the Diagnostic Accuracy of History,
Physical Examination, Imaging, and Lumbar
Puncture With an Exploration of Test
Thresholds
Christopher R. Carpenter, MD, MSc, Adnan M. Hussain, MD, Michael J. Ward, MD, MBA,
Gregory J. Zipfel, MD, Susan Fowler, Jesse M. Pines, MD, MBA, MSCE, and Marco L. A. Sivilotti, MD, MSc

Abstract
Background: Spontaneous subarachnoid hemorrhage (SAH) is a rare, but serious etiology of headache.
The diagnosis of SAH is especially challenging in alert, neurologically intact patients, as missed or
delayed diagnosis can be catastrophic.
Objectives: The objective was to perform a diagnostic accuracy systematic review and meta-analysis of
history, physical examination, cerebrospinal ﬂuid (CSF) tests, computed tomography (CT), and clinical
decision rules for spontaneous SAH. A secondary objective was to delineate probability of disease
thresholds for imaging and lumbar puncture (LP).
Methods: PubMed, Embase, Scopus, and research meeting abstracts were searched up to June 2015 for
studies of emergency department patients with acute headache clinically concerning for spontaneous
SAH. QUADAS-2 was used to assess study quality and, when appropriate, meta-analysis was conducted
using random effects models. Outcomes were sensitivity, speciﬁcity, and positive (LR+) and negative
(LR ) likelihood ratios. To identify test and treatment thresholds, we employed the Pauker-Kassirer
method with Bernstein test indication curves using the summary estimates of diagnostic accuracy.
Results: A total of 5,022 publications were identiﬁed, of which 122 underwent full-text review; 22 studies
were included (average SAH prevalence = 7.5%). Diagnostic studies differed in assessment of history and
physical examination ﬁndings, CT technology, analytical techniques used to identify xanthochromia, and
criterion standards for SAH. Study quality by QUADAS-2 was variable; however, most had a relatively
low risk of biases. A history of neck pain (LR+ = 4.1; 95% conﬁdence interval [CI] = 2.2 to 7.6) and neck
stiffness on physical examination (LR+ = 6.6; 95% CI = 4.0 to 11.0) were the individual ﬁndings most
strongly associated with SAH. Combinations of ﬁndings may rule out SAH, yet promising clinical
decision rules await external validation. Noncontrast cranial CT within 6 hours of headache onset
accurately ruled in (LR+ = 230; 95% CI = 6 to 8,700) and ruled out SAH (LR = 0.01; 95% CI = 0 to 0.04);
CT beyond 6 hours had a LR of 0.07 (95% CI = 0.01 to 0.61). CSF analyses had lower diagnostic
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accuracy, whether using red blood cell (RBC) count or xanthochromia. At a threshold RBC count of
1,000 9 106/L, the LR+ was 5.7 (95% CI = 1.4 to 23) and LR was 0.21 (95% CI = 0.03 to 1.7). Using the
pooled estimates of diagnostic accuracy and testing risks and beneﬁts, we estimate that LP only beneﬁts
CT-negative patients when the pre-LP probability of SAH is on the order of 5%, which corresponds to a
pre-CT probability greater than 20%.
Conclusions: Less than one in 10 headache patients concerning for SAH are ultimately diagnosed with
SAH in recent studies. While certain symptoms and signs increase or decrease the likelihood of SAH, no
single characteristic is sufﬁcient to rule in or rule out SAH. Within 6 hours of symptom onset,
noncontrast cranial CT is highly accurate, while a negative CT beyond 6 hours substantially reduces the
likelihood of SAH. LP appears to beneﬁt relatively few patients within a narrow pretest probability range.
With improvements in CT technology and an expanding body of evidence, test thresholds for LP may
become more precise, obviating the need for a post-CT LP in more acute headache patients. Existing
SAH clinical decision rules await external validation, but offer the potential to identify subsets most likely
to beneﬁt from post-CT LP, angiography, or no further testing.
ACADEMIC EMERGENCY MEDICINE 2016;23:963–1003 © 2016 by the Society for Academic Emergency
Medicine
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eadache is a common presenting complaint to
the emergency department (ED) and represents
approximately 2% of ED visits annually in the
United States.1 While most headaches are self-limiting,
the possibility of spontaneous subarachnoid hemorrhage (SAH) is an important diagnostic consideration in
patients presenting with a sudden, severe headache.
These sudden-onset headaches include the classic
“thunderclap headache” that instantaneously peaks at
headache onset, as well as headaches that reach maximal severity within seconds to 1 hour of onset. Suddenonset headaches include a wide spectrum of possible
diagnoses, including SAH (approximately 1% of acute
headaches), benign postcoital headache, exertional headache, intracranial cysts or tumors, intracerebral hemorrhage, hypophyseal apoplexy, sphenoid sinusitis, sinus
thrombosis, cough-related headache, vascular dissection,
cerebral vasospasm, and migraine headaches.2–10
Migraine and other more benign headaches mimic SAH
and are estimated to be at least 50 times more common
than SAH.11 Moreover, while SAH is often caused by a
ruptured cerebral aneurysm and represents a neurosurgical emergency, a variety of other SAH etiologies range
from the benign, low-pressure perimesencephalic hemorrhage, which can be treated conservatively,12,13 to vascular malformations, arterial dissection, and vasculitis,
which require time-sensitive interventions (Table 1).14
Thus, the diagnostic approach to acute headache
epitomizes the practice of emergency medicine with a
high-stakes condition without a clear-cut presentation
lurking within a high-volume complaint, and ultimately
most patients do not have a serious diagnosis.
Between 1960 and 1995, the 6-month mortality of
aneurysmal SAH decreased by 15%,15 but mortality
remains 27%–44% with substantial regional variability.16 Up to 25% of patients die within 24 hours, and the
3-month mortality rate can be as high as 50% without
early deﬁnitive treatment.17 In addition, one-third of
SAH survivors suffer neurologic deﬁcits affecting their
daily lives15 and up to 50% never return to work.18
Early detection and treatment can signiﬁcantly reduce
morbidity and mortality.11,19 However, SAH can be a
challenging diagnosis to make, particularly in alert, neurologically intact adults.20 Missed diagnosis is the

primary reason for delayed treatment and case series
suggest that 12%–53% of SAH cases are misdiagnosed
on their initial presentation in a variety of settings,
including the ED.21 Patients with misdiagnosed or undiagnosed warning bleeds that subsequently rebleed have
a 70% mortality.22–25 ED providers miss the diagnosis of
SAH in about 5% of cases, primarily those with lower
acuity at presentation and misdiagnosis is estimated to
be more likely in nonteaching hospitals.26,27 Most emergency medicine and neurosurgery textbooks provide
limited guidance on the diagnostic accuracy and utility
of history, physical examination, cerebrospinal ﬂuid
(CSF) analysis, or computed tomography (CT) for
the diagnosis of SAH.28,29 Indeed, given the serious nature of the condition, few have proposed a sensible
threshold below which testing is not necessary, which
contributes to overtesting and the unintended consequences that include incidental ﬁndings with prolonged
patient uncertainty.30
Unenhanced cranial CT is usually the ﬁrst-line diagnostic test to evaluate for suspected SAH. Because
early-generation CTs did not detect up to 5% of SAHs,
traditional teaching has emphasized the need to perform lumbar puncture (LP) to exclude SAH to reduce
the probability of error. Yet many patients fear having
an LP because an LP is painful and invasive and can
lead to a post-LP headache in 6%–30% of patients
Table 1
Potential Etiologies of Spontaneous SAH
Cerebral aneurysm
Perimesencephalic
Isolated convexity
Vascular malformations (arteriovenous malformations/
AVF)
Arterial dissection
Cerebral amyloid angiopathy
Moyamoya
Vasculitis (PRES, RCVS, lupus)
Coagulopathy (thrombocytopenia, anticoagulation)
Sickle cell disease
Hypertension
Sympathomimetic drugs
SAH = subarachnoid hemorrhage.
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depending on the gauge of the LP needle.31 Additional
clinician-level barriers to LP testing include the time
needed to perform32 and low diagnostic yield.20,33–36 In
addition, LP may be contraindicated if a patient has a
bleeding disorder or increased intracranial pressure or
simply does not consent to the procedure.37 Despite
dogma, LP is not always performed after CT and multicenter observational studies report that fewer than half
of acute headache patients undergo LP following a negative CT to “rule out” SAH. Even in these studies less
than one in 100 LPs are ultimately deemed “true positives” after negative CT using a third-generation scanner.38,39 Additionally, the speciﬁcity of LP is reduced by
“traumatic taps” in which bleeding from the procedure
contaminates the CSF being collected, estimated to
occur in about one in six LPs.40 Identifying xanthochromia due to the breakdown of hemoglobin in CSF is considered to be pathognomonic for SAH, yet
xanthochromia requires up to 12 hours to develop and
is prone to false positives due to ex vivo hemolysis or
hyperbilirubinemia.21,41 National guidelines in the United Kingdom advocate using spectrophotometry to
identify xanthochromia, yet nearly all North American
hospitals rely on visual inspection alone.42 A recent systematic review comparing visual inspection to spectrophotometry to detect CSF xanthochromia was unable
to draw a conclusion due to signiﬁcant heterogeneity in
the underlying studies.43
To our knowledge, there are no prior systematic
reviews assessing the diagnostic accuracy of history,
physical examination, and imaging studies for SAH in
the setting of acute-onset headache patients in the ED.
Therefore, we set out to collect and summarize the
available published literature regarding these characteristics as well as LP ﬁndings and clinical decision
rules for spontaneous (nontraumatic) SAH. Since recent
systematic reviews have evaluated CT angiography
(CTA)44 and magnetic resonance angiography (MRA),45
we did not repeat these meta-analyses. However,
additional studies exploring visible xanthochromia
diagnostic accuracy have been published since the 2014
systematic review by Chu et al.43 so we report an
updated meta-analysis of visible xanthochromia. We
also used these diagnostic accuracy estimates to delineate an optimal diagnostic strategy using the test–treatment threshold approach of Pauker and Kassirer.46,47
In particular, we used the graphical Bayesian approach
of test indication curves ﬁrst proposed by Bernstein48
to identify the a priori likelihood of disease in patients
for whom LP would be rational despite a negative
cranial CT.
METHODS
Study Design
We conducted a systematic review and meta-analysis of
original research studies that reported data on the diagnosis of SAH in ED patients with acute headache. The
design and manuscript structure conform to the recommendations from the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)49 and
the Meta-analysis of Observational Studies (MOOSE)
criteria.50 Studies were included if they described adult
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patients (14 years or older) seen in an ED with acute
headache or other symptoms or signs (such as syncope,
acute mental status change, or otherwise unexplained
nausea) and in whom SAH was a diagnostic consideration. In addition, studies had to report sufﬁcient detail
on the diagnostic test and criterion standard to be able
to construct two-by-two tables. We elected to deﬁne
“disease positive” as being an acute SAH including
nonaneurysmal SAH (e.g., perimesencepahlic hemorrhage) as most original studies did not distinguish
between SAH subtypes. We recognized that CT ﬁndings
of subarachnoid blood were therefore incorporated into
this deﬁnition, thereby inﬂating CT sensitivity, speciﬁcity, positive likelihood ratio (LR+), and negative likelihood ratio (LR ; incorporation bias), but report these
estimates for completeness.51 Recognizing the absence
of an accepted deﬁnition for a positive LP, we analyzed
separately an erythrocyte count above 1,000 9 106/L in
the ﬁnal tube as well as either visible or spectrophotometric xanthochromia. Patients with negative imaging
in whom LP was not performed were deemed as “disease negative” only when the authors reported effort at
follow-up after hospital discharge. We excluded studies
that solely reported data on patients with SAH (i.e.,
where only sensitivity could be calculated), precluding
an estimate of speciﬁcity or LRs.
Search Strategy
We searched the published literature using strategies
created for the concepts of emergency department,
headache, subarachnoid hemorrhage, physical exam,
and diagnostic accuracy. Search strategies were established using a combination of standardized terms and
keywords and were implemented in PubMed 1946–,
Embase 1947–, and Scopus 1823–. All searches were
completed in June 2015 and limited to English using
database supplied limits. Full search strategies for
PubMed and Embase are provided in the Data Supplement S1 (available as supporting information in the
online version of this paper). One author (AMH) independently reviewed the titles and abstracts to identify
potentially relevant articles. Where there were questions
about inclusion, this was discussed with a second
author (JMP) and a consensus decision was made about
whether the article should be included for full-text
review. Studies deemed not to contain clear inclusion or
exclusion criteria were evaluated by a second author
(JMP) before ﬁnal inclusion or exclusion.
Data from each study were independently abstracted
by two authors (AMH, CRC). Information abstracted
included the individual study setting, inclusion criteria,
exclusion criteria, speciﬁc CT (machine, slice number,
and type of CT image), deﬁnition of disease, criteria for
a positive LP, follow-up description, and whether or not
there was neurosurgical intervention. The abstracted
data were constructed into tables, which were conﬁrmed by a second author (CRC); any uncertainty was
discussed between the two authors and a consensus
decision was made. In addition, the references for each
full-text article were reviewed to assess whether additional studies could be included in the review, which
were then assessed by full-text review. The authors conducted bibliographic searches of research abstracts
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presented at scientiﬁc meetings published in Academic
Emergency Medicine, Annals of Emergency Medicine,
Stroke, Neurology, and Neurosurgery, from 2002
through October 2015.
Individual Evidence Quality Appraisal
Two authors (AMH, MJW) independently used the
Quality Assessment Tool for Diagnostic Accuracy
Studies (QUADAS-2)52 for systematic reviews to evaluate the quality of evidence for the studies identiﬁed.
These two authors used several a priori conditions to
evaluate an individual study’s risk of bias and degree of
applicability.

•

•
•

•
•

•

In the assessment of “inappropriate exclusions”
reviewers assessed whether a study’s inclusion and
exclusion criteria led investigators to evaluate suspected SAH patients who were more or less acutely
ill than those typically evaluated in ED settings,
which could introduce spectrum bias51 or spectrum
effect53 and skew observed estimates of sensitivity
(with sicker populations) or speciﬁcity (with less sick
populations) upward.
If the study setting was anything other than an ED
(for example, a neurosurgery clinic) then the results
were assessed as “low applicability.”
In the assessment of continuous data like CSF red
blood cells (RBCs), if the authors predeﬁned a
threshold
for
abnormal
(example,
CSF
RBC > 5 9 106 cells/L in the last tube is “abnormal”)
then the study results were assessed as “low risk” of
bias.
If the conduct of the index test differed from routine
care (example, xanthochromia assessed using only
spectrophotometry), then the results were assessed
as “low applicability.”
No widely accepted criterion standard for SAH yet
exists, so we accepted the criterion standard of subarachnoid blood on unenhanced CT of the head,
CSF xanthochromia, or CSF RBCs > 5 9 106/L in the
ﬁnal sample of CSF when any of these ﬁndings
included an aneurysm or arteriovenous malformation
evident on cerebral angiography, as previously
established by a consensus panel of emergency
physicians and a neurosurgeon.39,54 If less than
100% of a study’s subjects underwent cerebral
angiography, a surrogate outcome of medical record
review and structured telephone follow-up of at least
6-months were necessary.20 Any other criterion standard was assessed as “high risk” for bias.
Assessing whether the target condition is identiﬁed
is challenging in SAH diagnostic research. The ideal
patient-centric diagnostic test would identify SAH
patients with a lesion amenable to surgical or
endovascular intervention rendering measurable
beneﬁt in mortality and morbidity.55 Since perimesencephalic bleeds cause about 10% of SAH cases yet
require no intervention other than symptom control,
diagnostic studies that report aneurysmal SAH separately from perimesencephalic SAH would provide a
higher level of evidence by which to associate testing
with patient beneﬁt. Unfortunately, few SAH studies
report aneurysmal versus nonaneurysmal SAH

•

•

separately, so the decision was made that any SAH
identiﬁed using an acceptable criterion standard as
deﬁned above would be assessed as “high applicability.”
In assessing the uniformity of the criterion standard
reported, if all patients with nondiagnostic CT and
LP had either subsequent advanced imaging (angiography) or post-ED follow-up, then the risk of differential veriﬁcation bias was assessed as being
“low.”51
If a substantial number of patients were reported lost
to follow-up and no sensitivity analysis assuming
worst-case scenario (lost to follow-up = false-negative SAH index test), then the risk of bias was
assessed to be “high.”

Inter-rater QUADAS-2 reliability was assessed using
prevalence-adjusted, bias-adjusted kappa values to
adjust for unique biases between reviewers and the distribution of responses across categories.56 Discrepancies were then resolved by consensus.
Data Collection
We abstracted the study setting, study inclusion criteria,
the criterion standard employed to diagnose SAH, CT
technology, CSF analysis, follow-up procedures in
patients who did not undergo both CT and LP, disease
prevalence, and every variable on history, physical, or
testing for which a 2 9 2 diagnostic accuracy table
could be constructed. When reconstructed 2 9 2 contingency tables differed from the original investigators’
reports of sensitivity and speciﬁcity, we contacted the
authors for clarity.
Data Analysis
Meta-analysis estimates were computed by one author
(CRC) when ≥1 studies assessed the same ﬁnding on
history or physical examination or index testing. We
chose to combine unenhanced cranial CT studies without distinguishing speciﬁc generations of technology
since the detector number or geometry and the thickness of slices were frequently not speciﬁed. We generated combined estimates for diagnostic accuracy using
a random-effects model (Meta-DiSc Version 1.4,
 n y Cajal).57,58 Interstudy
Hospital Universitario Ramo
heterogeneity was assessed using the Der-SimonianLaird random effects model and the index of inconsistency (I2).59,60 Pooled estimates of dichotomous LR+
and LR are also reported from the random-effects
model. Publication bias was not assessed because this
is not an accepted approach in diagnostic meta-analyses due to the small number of studies generally
identiﬁed.61
The added value of LRs over positive and negative
predictive values is that likelihood ratios are independent of disease prevalence.62 In addition, LRs can be
used on an individual patient to estimate posttest probabilities, unlike sensitivity and speciﬁcity.63 Larger LR+
increase the posttest probability of a disease more than
smaller values of LR+; similarly, smaller LR decrease
the posttest probability of a disease more than larger
values of LR . Note that a LR of 1 does not change the
posttest probability at all. One rule of thumb is that
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LR+ > 10 and LR
value.64

< 0.1 provide considerable diagnostic

Test–Treatment Threshold
We used the Pauker-Kassirer method to estimate
thresholds for further testing or treatment.47 This
technique is based on the diagnostic accuracy of a
test, as well as the estimated risks of testing and of
treatment, and the anticipated beneﬁt of treatment.
We performed a separate analysis for each of the two
primary tests in question, namely, cranial CT (stratiﬁed by time post–headache onset) and LP (using
either CSF RBC or visible xanthochromia to deﬁne
“positive LP”). We used the pooled estimates from the
meta-analysis for test sensitivity and speciﬁcity and
our collective clinical experience and selected references to estimate risks and beneﬁts. We extended the
test indication curve method ﬁrst proposed by Bernstein48 to visually represent this analysis. Speciﬁcally,
the curves display how the information conveyed by a
positive or negative test result affects a given patient’s
posttest probability of disease relative to the treatment
threshold. These test indication curves were originally
developed to illustrate the pretest probability at which
testing is no longer indicated based only on the net
utilities of treating or not treating patients with and
without disease.46 We extended this graphical
approach to incorporate the nonzero risks of testing,
which necessarily narrow the range of probabilities
for which testing remains rational.47,65 Because the
precise utilities of both testing and treatment are difﬁcult to estimate on a common scale, we performed
sensitivity analyses by doubling and halving the calculated treatment threshold (i.e., the ratio of risks of
treatment to the sum of risks and beneﬁts)48 and also
by reducing the risk of testing by half and

PUBMED search
idenﬁed 367 arcles

Hand search of scienﬁc
assemblies idenﬁed 1
abstract

967

recalculating the test thresholds. Recognizing that
these estimates are nevertheless somewhat arbitrary,
we also provide an interactive calculator to permit
readers to recompute thresholds using different estimates of test performance or anticipated risks and
beneﬁts that may be more applicable to the end-users’
patient populations and clinical environments (Data
Supplement S3, available as supporting information in
the online version of this paper).
In developing the test–treatment threshold, we were
most interested in the common clinical dilemma of
whether to perform LP after a negative cranial CT or
to forgo LP and proceed directly to angiography.
Because CT-positive or LP-positive patients do not
immediately undergo neurosurgical clipping or
endovascular coiling, the next step being contemplated
is usually angiography, typically by CT or MRA (and
sometimes by digital subtraction ﬂuoroscopy), followed
by intervention when a culprit aneurysm is identiﬁed.
Therefore, for Pauker-Kassirer modeling we designated the “test” of interest as being either the unenhanced CT or the LP and the “treatment” as being
angiography. Furthermore, because an LP is usually
done after a negative CT, we considered how a negative unenhanced cranial CT would affect the post-CT
(i.e., pre-LP) probability of still having a SAH across
the range of pre-CT probabilities.
RESULTS
A total of 5,022 citations were identiﬁed through a
search of PubMed, Embase, and Scopus. From this
search, 399 duplicate citations were removed. A total of
122 studies underwent full-text review; of these, 22 studies were included in the current analysis (Figure 1 and
Table 2). Although most studies enrolled only awake

EMBASE search
idenﬁed 3454 arcles

SCOPUS search
idenﬁed 1200 arcles
5022 manuscripts and
abstracts idenﬁed
399 duplicates removed and 14
manuscripts unavailable

4487 excluded aer reviewing
tles/abstracts
122 full manuscripts reviewed

100 arcles excluded
• SAH only (28)
• No original data (27)
• Inability to reconstruct 2x2 tables
(21)
• Editorial (18)
• Not SAH (4)
• Duplicate paents (2)

22 primary studies included in
this systemac review

Figure 1. Study selection process. SAH = subarachnoid hemorrhage.

Pitt County
Memorial
Hospital,
Greenville
SC, 2002
Uppsala
University
Hospital,
Uppsala
Sweden,
2009–2011

Boesiger
2005

Naval Medical
Center, San
Diego, CA,
Jul 2002–Jul
2004

Unspecified
urban
tertiary care
hospital,
2001–2009

Carstairs
2006

Czuczman
2013

Brunell 2013

Akershus
University
Hospital,
Norway,
1998–2002

Bo 2008

Location

University
Medical
Center,
Utrecht, the
Netherlands,
2005–2012

Backes 2012

Study

Table 2
Summary of Included Studies

Setting

ED

ED

Hospital

ED

ED

ED

220

116

453

177

433

250

No.
Patients

44

39

NR

NR

44

48*

Mean
Age
(y)*
Inclusion Criteria

Adults with
headaches
billed for LPs,
≥5 RBCs in final
CSF tube, and
either CT
angiogram or
magnetic
resonance
angiogram
within 2 wk

Age > 18 y with
either worst
headache of life
or onset <60 s
or associated
neuro deficit

Adults with
headache
workup
including CT
and LP
Age > 10 y with
LP to exclude
SAH

Age >14 y, acuteonset worst
headache of life

Age >16 y,
clinical
suspicion of
acute onset
SAH, GCS 15

Study Design

Retrospective
case series.

Prospective
observational
consecutive
sampling
cohort.

Lab
information
system
review.

Retrospective
chart review.

Two
prospective
databases.
First database
consecutive
patients with
confirmed
SAH. Second
all LP patients
with SPT.
Prospective
observational
consecutive
sampling
cohort.

CSF hemoglobin
detection via SPT
using 415-nm
wavelength or CSF
bilirubin detection
via automatic
analyzer.
SAH observed on CT
or RBCs in CSF
tube 1 that did not
clear by >25% in
tube 4 or presence
of xantho on visual
inspection by lab.
Either 1) presence of
SAH on imaging; 2)
xantho with
aneurysm or AVM >
2 mm; 3) xantho
and culture- or
PCR-negative
meningitis.

SAH observed on CT
or ≥400 RBCs in
CSF tube 1 that did
not clear by 10-fold.

Consensus between
two neurologists,
but not explicitly
defined.

Not explicitly
defined.

SAH Criterion
Standard

11.8

4.3

1.1

3.4

16.4

42.0

SAH
Prevalence
%
Variables Assessed

Sen/Spec of
elements of
history including
sudden onset
headache, worst
headache, and
onset with
exertion; CSF RBC
iLRs.

Sen/Spec of CTA
and elements of
history including
stiff neck, blurred
vision, and altered
mental status.

Sen/spec of CSF
RBC for SAH.

Sen/Spec of
elements of
history including
activity at onset
and peak intensity
for SAH.
Sen/Spec of CT for
SAH.

Sen/Spec CT at <6
and >6 h for SAH.

Follow-up

None

None

(Continued)

Phone f/u at 1 y
if ≥400 RBCs in
CSF tube 1 that
did not clear by
10-fold.
None

None

None
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Location

Royal
Brisbane &
Women’s
Hospital, Jun
2005–Jul
2012

University
Hospital,
€ ping,
Linko
Sweden,
over
unspecified
31-month
period

Utrecht
University
Hospital,
Utrecht, the
Netherlands,
Jan 1992–Oct
1994

Landtblom
2002

Linn 1998

^ pital de
Ho
l’Enfant sus,
Je
Quebec,
Canada, 2003
–2009

St. Mary’s
Hospital,
Rochester,
MN, 1998–
2007

Hann 2015

Gangloff
2015

Dupont 2008

Study

Table 2 (continued)

Setting

ED

ED

ED

ED

ED

102

137

409

706

117

No.
Patients

48

42*

38

41

45

Mean
Age
(y)*

Age > 18 y
presenting
within 10 d of
headache onset
with abrupt
onset (<10 s)
headache,
examined by
on-call
neurologist
Alert adult
patients without
focal neuro
deficit referred
to ED by
general
practitioner with
concern for
SAH with CT
and LP
Prospective
observational
cohort.

Prospective
observational
cohort.

Retrospective
case series.

Retrospective
case series.

Study Design
Retrospective
chart review.

Inclusion Criteria
Age > 18 y with
headache onset
<2 wk prior with
both
noncontrast CT
for detection of
blood and LP
Age > 14 y with
acute headache
suspicious for
SAH, GCS 15,
and initial head
CT negative for
SAH with
subsequent LP
Adults
discharged with
headache after
CSF evaluation
for xantho

Not specified.

Presence of vascular
aneurysm on
angiogram within
30 d of headache or
no repeat ED visit
or SAH death in 30
d.
Not specified.

Presence of any
aneurysm and
presence of either
visual xantho or
>5 9 106 RBCs/L in
last CSF tube.

Not specified.

SAH Criterion
Standard

41.2

11.3

1.5

0.7

12.0

SAH
Prevalence
%
Variables Assessed

Sen/Spec of
elements of
history including
activity at onset
and acuity of
onset.

Sen/Spec of
elements of
history including
sudden onset
headache, worst
headache, and
nausea.

Sen/Spec visual
xantho via visual
inspection.

Sen/Spec visual
xantho, iterative
SPT, or U.K.
NEQUA SPT.

Sen/Spec visual
xantho for
aneurysm.

Follow-up

None

(Continued)

Phone at 24 days, 79 days, and 1-,
3-, 6-, and 12months for 90
subjects without
SAH

Review of
Queensland
death registry

None

None
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Hermann
Hospital,
Houston, TX,
Mar 1995–
Jun 1996

Unspecified
hospital over
unspecified
1-year period

Six Canadian
tertiary care
EDs, Jul
2002–Jan
2004

Six Canadian
tertiary care
EDs, Nov
2000–Nov
2005

11 Canadian
tertiary care
EDs, Nov
2000–Dec
2009

O’Neill 2005

Perry 2006

Perry 2010

Perry 2011

Location

Morgenstern
1998

Study

Table 2 (continued)

ED

ED

ED

ED

ED

Setting

3,132

1,999

220

116

97

No.
Patients

45

43

42

NR

39

Mean
Age
(y)*

Prospective
cohort study.

Prospective
cohort study.

Age > 15 y with
acute,
spontaneous
headache with
or without
syncope

Preplanned
substudy of
prospective,
consecutive
patient cohort
study.

Retrospective
chart review.

Prospective
observational
cohort.

Study Design

Age ≥ 16 y with
spontaneous
headache
peaking within
1 h or syncope
associated with
a headache

Acute headache
< 24 h, clinical
suspicion SAH,
referred for CT
from ED
Age > 15 y with
acute,
spontaneous
headache with
or without
syncope

Adult patients
with 10/10
worst headache
of life

Inclusion Criteria

Any one of the
following:
subarachnoid blood
on CT, >5 9 106/L
RBCs in 3rd or 4th
tube of CSF, or
visible xantho +
aneurysm on
cerebral
angiography.
Any one of the
following:
subarachnoid blood
on CT, visual
xantho, >5 9 106/L
RBCs in the final
tube of CSF with an
aneurysm or AVM
on cerebral
angiography.
Any one of the
following:
subarachnoid blood
on CT, visual
xantho, >5 9 106/L
RBCs in the final
tube of CSF with an
aneurysm or AVM
on cerebral
angiography.

Either 1) presence of
SAH on imaging or
2) CSF RBCs >
1,000 with <25%
decrement from
first to last tube
with either visual
xantho, SPT
xantho, or elevated
D-dimer.
Not specified.

SAH Criterion
Standard

7.7

Phone f/u at 1and 6-months
for all patients
without CT or
LP; chart review
& provincial
coroner’s
records at study
end for same
patients

Sen/Spec CT at <6
and >6 h for SAH.

(Continued)

Phone f/u at 1and 6-months
for all patients
without CT or
LP; chart review
& Ontario
registry review
at study end for
same patients

Phone f/u at 1month for CT-,
LP- patients;
chart review at
1-month for all
patients

None

Phone f/u at
mean
24 months

Follow-up

Sen/Spec of
elements of
history including
activity at onset,
neck stiffness, and
arrival mode.
Also, derivation of
three CDRs.

Sen/Spec of visual
inspection for
xantho and four
SPT methods for
xantho for SAH.

0.9

6.5

Sen/Spec of CT for
SAH.

Sen/Spec of
elements of
history and
physical
examination
including nausea,
stiff neck, and
lethargy.

Variables Assessed

16.4

18.6

SAH
Prevalence
%
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12 Canadian
tertiary care
EDs, Apr
2006–Jul
2010

University
hospitals in
Utrecht and
Rotterdam
the
Netherlands,
1989–1993
Princess
Alexandra
Hospital,
Brisbane,
Queensland,
Australia,
Jan 2000–
Apr 2003

Perry 2015

Van der Wee
1995

NR

NR

ED

ED

Setting

240

175

1,7391,098
normal
LP641
abnormal
LP

2,131

No.
Patients

NR

NR

44

44

Mean
Age
(y)*

Preplanned
substudy of
prospective,
consecutive
patient cohort
study.

Age > 15 y with
acute,
spontaneous
headache with
or without
syncope with LP
to evaluate
potential SAH

Acute or
unusually
severe
headache with
LP after a
normal cranial
CT for possible
diagnosis of
SAH

Retrospective
chart review.

Unclear
whether
retrospective
or prospective
“consecutive”
case series.

Prospective
cohort study.

Age ≥ 16 y with
spontaneous
headache
peaking within
1 h or syncope
associated with
a headache

Acute headache
without
confusion or
focal deficit
with CT within
12 h

Study Design

Inclusion Criteria

Uniform CSF blood
staining across
serial samples with
visual xantho and
“positive”
angiography.

Not specified.

Aneurysmal SAH if
subarachnoid blood
on CT, visual
xantho, or any
RBCs in the final
tube of CSF with an
aneurysm on
cerebral
angiography.

Any one of the
following:
subarachnoid blood
on CT, visual
xantho, >5 9 106/L
RBCs in the final
tube of CSF with an
aneurysm or AVM
on cerebral
angiography.

SAH Criterion
Standard

0.8

68

2.3

6.2

SAH
Prevalence
%

Sen/Spec of CSF
SPT (XI > 0.080).

Sen/Spec CT at <12
h for SAH.

Sen/Spec of
elements of
history and
physical
examination
including activity
at onset, neck
stiffness, and
arrival mode.
Also, derivation of
four SAH CDRs.
Sen/Spec of
<2000 9 106/L
RBCs in CSF + no
xantho for
diagnosis
aneurysmal SAH.

Variables Assessed

None

Phone f/u at 1and 6-months
for all patients
without CT or
LP; chart review
& provincial
coroner’s
records at study
end for same
patients
None

Phone f/u at 1and 6-months
for all patients
without CT or
LP; chart review
& provincial
coroner’s
records at study
end for same
patients

Follow-up

AVM = arteriovenous malformations; CDR = clinical decision rule; CSF = cerebrospinal fluid; CT = computed tomography; f/u = follow-up; GCS = Glasgow Coma Scale; iLRs = interval likelihood ratios; LP = lumbar puncture; NR = not reported; SAH = subarachnoid hemorrhage; Sen/Spec = sensitivity/specificity; SPT = spectrophotometry; xantho = xanthochromia; XI = xanthochromic index.
*Median.

Wood 2015

10 Canadian
tertiary care
EDs, Nov
2000–Dec
2009

Location

Perry 2013

Study

Table 2 (continued)

ACADEMIC EMERGENCY MEDICINE • September 2016, Vol. 23, No. 9 • www.aemj.org
971

YES
YES
YES

YES
YES

YES

NO
YES

NO
YES

YES
YES

YES
NO
YES
YES
YES
YES
NO

NO
0.33

Consecutive
Consecutive
Consecutive

Consecutive
Consecutive

Consecutive

Consecutive
Consecutive

Consecutive
Consecutive

Consecutive
Consecutive

Consecutive
Consecutive
Consecutive
Consecutive
Consecutive
Consecutive
Consecutive

Consecutive
1.00

Sample

NO
0.52

YES
YES
YES
YES
YES
YES
NO

YES
YES

NO
YES

YES
YES

NO

YES
YES

YES
YES
YES

NO
0.05

YES
YES
YES
YES
YES
YES
NO

NO
YES

NO
NO

NO
NO

YES

YES
YES

NO
NO
NO

Blinded Interpretation of
Index Test?

*Prevalence-adjusted, bias-adjusted kappa as defined by Byrt et al.56

Backes 2012
Bo 2008
Boesiger
2005
Brunell 2013
Carstairs
2006
Czuczman
2013
Dupont 2008
Gangloff
2015
Hann 2014
Landtblom
2002
Linn 1998
Morgenstern
1998
O’Neill 2005
Perry 2006
Perry 2010
Perry 2011
Perry 2013
Perry 2015
van der Wee
1995
Wood 2005
Kappa*

Study

Avoided Inappropriate
Exclusions?

Patients
and Settings Match
Study
Question?

Table 3
Overview of Quality Assessment of Included Studies

NO
0.14

YES
YES
YES
YES
YES
YES
NO

YES
NO

NO
NO

YES
NO

YES

NO
YES

YES
NO
YES

Acceptable
Index Test
Application?

NO
0.05

NO
YES
YES
YES
YES
YES
NO

NO
NO

YES
YES

YES
YES

YES

NO
YES

NO
NO
YES

Acceptable
Reference
(Criterion)
Standard?

NO
0.05

YES
NO
NO
YES
YES
NO
NO

NO
YES

NO
NO

NO
NO

NO

YES
YES

NO
NO
YES

Outcomes
Assessed
by Blinded
Assessor?

YES
0.43

YES
YES
YES
YES
YES
YES
NO

YES
NO

YES
YES

YES
YES

YES

NO
YES

NO
NO
NO

Assessed
Outcomes
Pertinent?

NO
0.52

YES
YES
YES
YES
YES
YES
YES

YES
YES

YES
YES

YES
YES

YES

YES
YES

YES
YES
YES

Appropriate
Interval Between
Index Test and
Reference Standard?

YES
0.62

YES
YES
YES
YES
YES
YES
YES

NO
YES

YES
YES

NO
NO

YES

YES
YES

YES
YES
YES

Same Reference (Criterion) Standard for All
Patients?

YES
0.33

NO
YES
NO
NO
YES
YES
YES

YES
NO

YES
YES

YES
NO

YES

YES
YES

YES
YES
YES

All Patients
Analyzed?
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Table 4
Single-study Predictors of SAH from History and Physical Examination Available
Risk Factor

Sensitivity, % (95% CI)

Diplopia
Landtblom 2002
0
Family history cerebral aneurysm
Czuczman 2013
0
Lethargy
Morgenstern 1998
39
Onset < 1 min
Linn 1998
50
Onset 1–5 min
Linn 1998
24
Onset < 1 h
Bo 2008
100
PMH of chronic headache
Czuczman 2013
19
PMH of hypertension
Czuczman 2013
31
Scotomata
Landtblom 2002
0
Similar headache in past
Linn 1998
19
LR+ = positive likelihood ratio; LR

Specificity, % (95% CI)

LR+ (95% CI)

LR

(95% CI)

(0–15)

98 (94–100)

0.96 (0.05–19.33)

1.00 (0.94–1.07)

(0–13)

92 (87–95)

0.22 (0.01–3.54)

1.07 (1.00–1.15)

(17–64)

82 (72–90)

2.19 (1.04–4.64)

0.74 (0.51–1.09)

(34–66)

45 (32–58)

0.91 (0.62–1.33)

1.11 (0.74–1.68)

(12–39)

87 (75–94)

1.79 (0.77–4.14)

0.88 (0.72–1.07)

(95–100)

12 (9–16)

1.13 (1.09–1.19)

0.06 (0–0.95)

(7–39)

79 (73–85)

0.93 (0.40–2.91)

1.02 (0.83–1.24)

(14–52)

80 (74–85)

1.53 (0.81–2.91)

0.87 (0.66–1.13)

(0–15)

93 (87–97)

0.28 (0.02–4.72)

1.06 (0.98–1.14)

(9–34)

90 (79–96)

1.90 (0.71–5.09)

0.90 (0.76–1.07)

= negative likelihood ratio; PMH = past medical history; SAH = subarachnoid hemorrhage.

Ambulance Arrival

Figure 2. Forest plots for diagnostic elements of history for SAH. LR = likelihood ratio; SAH = subarachnoid hemorrhage.
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Awoke from Sleep

Figure 2. Continued.

and alert patients with a Glasgow Coma Scale score
of 15, some also included those with decreased level
of consciousness, which could introduce spectrum
effect into observed estimates of diagnostic accuracy.
All studies were conducted in North American or
European countries. Each study included the presence
of subarachnoid blood on unenhanced cranial CT as
representing “disease positive.” Descriptors of the
speciﬁc technology utilized for CT scanners and spectrophotometric assessment for CSF xanthochromia
were inconsistent. Deﬁnitions of xanthochromia ranged from direct visual inspection to spectrophotometric analysis. When using spectrophotometry, studies
varied with regards to wavelengths sampled and
speciﬁc algorithms used to adjust for interference by
oxyhemoglobin, protein, and other corrections. Clinical
follow-up proportion varied considerably, ranging

from no follow-up to complete follow-up with crosschecking of coroner records to ensure no missed
deaths. Assessment of studies by QUADAS-2 (Table 3)
showed signiﬁcant heterogeneity in reference standards used, blinding of index test interpreters to the
reference standard, and vice versa. Agreement
between reviewers was fair for all QUADAS-2 elements except for index and reference standard blinding,
reference
standard
appropriateness,
and
acceptable application of index test in which cases the
agreement was poor.66 However, most studies had a
relatively low risk of biases overall.
Prevalence
The overall prevalence of SAH in these studies ranged
from 0.91% to 68%. In prospective studies within the
past 10 years, the prevalence ranged from 0.91% to

ACADEMIC EMERGENCY MEDICINE • September 2016, Vol. 23, No. 9 • www.aemj.org

975

Blurred Vision

Figure 2. Continued.

17% with a weighted average of 7.5%. Two of the studies with the lowest prevalence enrolled patients undergoing LP following a negative CT.67,68
History and Physical Examination
Eight studies described the diagnostic accuracy for 22
components of history2,17,33,38,39,69–71 (Table 4 and
Figure 2) and six studies described the diagnostic accuracy for four physical examination tests2,17,69,70 (Table 4
and Figure 3) for SAH. Within these studies there was
signiﬁcant heterogeneity in the manner in which history
and physical characteristics were obtained and deﬁned.
For example, Perry et al.39 deﬁned limited neck ﬂexion
on physical examination as “inability to touch chin to
chest or raise the head 8 cm off the bed if supine,”
whereas Carstairs et al.17 provided no descriptor of how
“nuchal rigidity” was objectively assessed on physical
examination. Perry et al.39 reported the interphysician

reliability of elements of the history and physical examination, with kappa (j) values ranging from 0.44 to 1.00.
The least reliable ﬁndings were thunderclap headache
(j = 0.49) and limited neck ﬂexion (j = 0.44).
No single element of history had a very high pooled
LR+. The ﬁndings on history that increased the probability of SAH the most included subjective neck stiffness
(LR+ = 4.12, 95% CI = 2.24 to 7.59), while the absence of
“worst headache of life” (LR = 0.36, 95% CI = 0.01 to
14.22) or onset of headache over more than 1 hour
(LR = 0.06, 95% CI = 0 to 0.95) each reduced the probability of SAH.
On physical examination, neck stiffness (LR+ = 6.59,
95% CI = 3.95–11.00) was strongly associated with SAH
as reported in three studies, but no single physical
examination ﬁnding had a LR less than 0.74. Most elements of history and physical examination demonstrated signiﬁcant statistical heterogeneity.
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Burst or Explode at Onset

Figure 2. Continued.

Clinical Decision Rules
Four related SAH clinical decision rules have been
described, three of which were prospectively validated
in a subsequent study by the same investigator group to
generate the ﬁnal reﬁned Ottawa SAH Rule. Since more
than one study is needed to perform a meta-analysis,
we were unable to pool diagnostic accuracy results for
SAH Clinical Decision Rules. The component elements

of each decision rule, along with their combined accuracy and reliability are available in Data Supplement S2
(available as supporting information in the online version of this paper). Rule 1 appears sufﬁcient to rule out
SAH (LR = 0.06, 95% CI = 0.01–0.22), was uncomfortable to use for only 18% of surveyed emergency physicians, was misinterpreted in 4.7% of cases, and would
theoretically decrease CT and/or LP testing rates from
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ED Transfer

Figure 2. Continued.

84% to 74%. On the other hand, the Ottawa SAH Rule
more accurately rules out SAH (LR = 0.02, 95%
CI = 0.00–0.39), but could increase CT and/or LP testing
rates if strictly applied.39
Advanced Imaging
Five studies examined the diagnostic accuracy of noncontrast CT (Figure 4).20,72–75 The pooled estimate for
sensitivity was 94% (95% CI - 91% to 96%, I2 = 74%)
and LR was 0.07 (95% CI = 0.03 to 0.17, I2 = 78%). van
der Wee et al.72 assessed CT accuracy at 12 hours, but
did not provide sufﬁcient data to reconstruct 2 9 2
tables stratiﬁed by that time threshold. Three other
studies reported diagnostic accuracy stratiﬁed by the
time interval since symptom onset, but only two
reported the threshold of less than 6 hours.20,70,75
Pooled sensitivity within the ﬁrst 6 hours of symptom
onset was 100% (95% CI = 98% to 100%, I2 = 0%) and
LR was 0.01 (95% CI = 0 to 0.04, I2 = 0%). Beyond

6 hours the pooled sensitivity of CT was 89% (95%
CI = 83% to 93%, I2 = 89%) and LR was 0.07 (95%
CI = 0.01 to 0.61, I2 = 63%).
CSF Erythrocytes and Xanthochromia
Six studies examined diagnostic accuracy of xanthrochromia on CSF analysis, but investigators used
variable methods to assess xanthochromia ranging from
visible inspection33,67,68,76 to multiple different spectrophotometric assays (Table 5, Figure 5).34,67,68,77 For
visible xanthochromia the pooled meta-analysis results
were as follows: sensitivity was 85% (95% CI = 66% to
96%, I2 = 0%), speciﬁcity as 97% (95% CI = 96% to
98%, I2 = 13%), LR+ was 24.67 (95% CI = 12.13 to 50.14,
I2 = 64%), and LR was 0.22 (95% CI = 0.09 to 0.54,
I2 = 13%). Both Perry and Gangloff evaluated spectrophotometric bilirubin using the U.K. National External Quality Assessment Service (U.K. NEQAS)
algorithm78 with pooled sensitivity of 100% (95%
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Exertion at Onset

Figure 2. Continued.

CI = 59% to 100%, I2 = 0%), speciﬁcity of 95% (95%
CI = 93% to 96%, I2 = 98%), LR+ of 15.23 (95% CI = 1.58
to 146.73, I2 = 96%), and LR of 0.13 (95% CI = 0.02 to
0.83, I2 = 0%).67,68 The diagnostic accuracies of other
spectrophotometric methods to evaluate for CSF bilirubin are also summarized in Table 5.
Two studies evaluated CSF erythrocyte counts to distinguish a traumatic LP from an aneurysmal SAH. Perry
et al.79 noted a sensitivity of 93% (95% CI = 68% to
100%), speciﬁcity of 91% (95% CI = 88% to 93%), LR+

of 10.25 (95% CI = 7.7 to 13.6), and LR of 0.07 (95%
CI = 0.01 to 0.49) at a threshold CSF RBC < 2,000 9 106/
L in the ﬁnal tube of CSF collected. Czuczman et al.33
reported interval likelihood ratios (iLR)80 for CSF RBC
counts in the ﬁnal tube collected (using units of cells/
lL): iLR<100 = 0, iLR100–10,000 = 1.6, iLR>10,000 = 6.3. Using
raw data from these two studies to evaluate the summary diagnostic accuracy for CSF RBC in the ﬁnal tube
at an arbitrarily selected new threshold of 1,000 9 106/
L, the pooled sensitivity was 76% (95% CI = 60% to
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Figure 2. Continued.

88%, I2 = 79%), speciﬁcity was 88% (95% CI = 86% to
90%, I2 = 95%), LR+ was 5.7 (95% CI = 1.4 to 23,
I2 = 97%), and LR was 0.21 (95% CI = 0.03 to 1.66
I2 = 78%). The diagnostic accuracy of CT and LP, and
speciﬁcally how the test results affect the posttest probability of disease in a Bayesian fashion, are represented
in Figure 6.

Test–Treatment Threshold
The risks of treatment (designated Rrx by Pauker and
Kassirer47) were primarily those ascribed to angiography itself and not those of eventual neurosurgical intervention. These risks included additional exposure to
ionizing radiation and to contrast, the risks of vascular
access and allergic reactions, and the remote risk of
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Intercourse at Onset

Figure 2. Continued.

stroke or other end-organ damage. The lifetime risk of
malignancy secondary to exposure to ionizing radiation
is a function of dose and age; an adult is typically
exposed to 20 mGy radiation during cranial CT. Using
an average lifetime cancer risk attributable to such an
exposure of almost 1%,81 we deemed the total risks
related to angiography to be relatively low at 0.02.
When considering the beneﬁts of treatment (Brx), we
considered primarily the beneﬁts of treating an
aneurysmal SAH. Overall, SAH has 12% mortality prior
to arrival in the ED and 40% in-hospital mortality at
1 month despite treatment. In addition, one-third of survivors
suffer
a
severe
neurologic
deﬁcit.82,83

Neurosurgical and interventional radiology treatment
options include clipping and coiling the culprit aneurysm when present, with several large randomized trials
reporting long-term poor outcomes in up to 35% of
treated subjects.84–86 The long-term beneﬁts of early
diagnosis and treatment in the subset of patients who
present awake and neurologically intact are not well
characterized but presumably somewhat better, so we
assigned an optimistic overall treatment beneﬁt (Brx) of
0.8 with immediate diagnosis.
For LP we considered the common morbidity of a
postdural puncture headache, discomfort, and remote
risks of infection and assigned a test risk (Rt) of 0.01.

ACADEMIC EMERGENCY MEDICINE • September 2016, Vol. 23, No. 9 • www.aemj.org

981

Loss of Consciousness
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The testing thresholds from these estimates of potential
risk and potential beneﬁt are depicted in Figure 7. The
thresholds bracketing indifference between LP versus
either no further testing (Ttest) or angiography (Ttreat)
were very narrow, suggesting that LP should only be
considered for patients with a pre-LP probability
between 2 and 7% (when using visible xanthochromia)
or between 2 and 4% (when using CSF erythrocyte
count). Lower-risk patients need no further testing and
avoid LP, while higher-risk patients beneﬁt from
angiography and again avoid LP.

Of note, these rather narrow pre-LP probability
bands correspond to the post-CT disease probability,
not the original estimate based on history and physical
examination (i.e., not the pre-CT estimate). In other
words, one should take the pre-CT probability estimate
and incorporate the information gained from a negative CT in a Bayesian fashion. The impact of a negative
CT on the post-CT (i.e., pre-LP) probability is also
shown in Figure 7, depending on the interval between
headache onset and imaging. Thus, a pre-LP probability of 2% to 7% represents a pre-CT prior probability
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Figure 2. Continued.

of over 70% (based on history and physical) for a CT
obtained within 6 hours and over 20% for a CT
obtained beyond 6 hours. The sensitivity analyses
showed that these estimates were stable across a
range of utilities and were primarily inﬂuenced by the
diagnostic accuracy of the tests being considered, as
illustrated in the ﬁgures. When the risks of testing (LP)
were allowed to approach the risks of treatment (angiography), then LP was no longer indicated at any
pretest probability. Table 6 provides an example illustrating how to use test indication curves for diagnostic
decision-making.

DISCUSSION
The results of this systematic review demonstrate that
neither the presence nor the absence of commonly cited
SAH risk factors from history and physical examination
accurately rule in or rule out this potentially lethal diagnosis. Speciﬁcally, no single history or physical examination ﬁnding signiﬁcantly increases (LR+ > 10) or
decreases (LR < 0.1) the posttest probability of SAH
for severe headaches that peak within 1 hour of onset.
In addition, many elements of history and physical
examination for SAH have only fair to good
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Nausea

Figure 2. Continued.

interphysician reliability, with the characterization of
the headache as “thunderclap” being one of the least
reproducible ﬁndings.39 Nonetheless, many physicians
would prefer to never miss a SAH, and missed SAH
remains an important cause of litigation in emergency
medicine.23,87
Lacking accurate features on clinical presentation and
recognizing the tension between malpractice risk and a
growing imperative to preserve limited healthcare
resources,
to
adhere
to
Choosing
Wisely

recommendations,23,87,88 and to avoid the unintended
harms of overdiagnosis,30 clinical researchers have
endeavored to develop more efﬁcient prediction instruments. Yet the development of highly sensitive instruments requires both large data sets and rigorous
adherence to methodologic standards. To illustrate, a retrospective validation of Rule 1 using medical record
review in Northern California reported a LR of 0.13
(95% CI = 0.03 to 0.61) and reportedly missed 11 cases
(20%) of SAH cases despite cranial CT within 6 hours.89
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Neck stiffness, subjective

Figure 2. Continued.

Another retrospective study of aneurysmal SAH patients
demonstrated 100% sensitivity (95% CI = 97.6% to
100%) using the combination of negative cranial CT and
all negative responses on the Ottawa SAH Rule.90 However, validating a clinical decision rule retrospectively is
suboptimal since all components of the rule may not be
recorded in the medical records and whether to code

missing variables as unknown or not present is frequently a question.91 In the retrospective validation of
Rule 1, the “onset during exertion” variable was missing
in one-third of patients.92 Therefore, these instruments
should ideally undergo prospective validation in different
settings before widespread adoption (J. J. Perry et al.,
manuscript submitted for publication).91
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Unenhanced CT remains the ﬁrst-line imaging test in
ED headache patients with suspected spontaneous
SAH. Within 6 hours of headache onset, CT demonstrates sufﬁcient accuracy to rule in or to rule out SAH,
notwithstanding the heterogeneity of the estimated
speciﬁcity and LR+ of the two studies identiﬁed. Beyond
6 hours the estimated LR (95% CI = 0.01 to 0.61) and
sensitivity (95% CI = 83% to 93%) become less precise
and concerns regarding heterogeneity (I2 = 89% and
I2 = 63%, respectively) allow the interpretation that the
accuracy of cranial CT to rule out SAH could range
from very good (LR = 0.01) to unhelpful (LR = 0.61)
taking the extremes of the 95% CI. Therefore, the timing

of CT relative to symptom onset has remained an
important qualiﬁer when estimating the diagnostic
accuracy of the CT. Of course, CT can identify other
causes of headache or other abnormalities and similarly
can miss SAH due to cervical arteriovenous malformations.75 Some researchers in the ﬁeld stipulate that the
CT should be interpreted by an experienced neuroradiologist, although recent research indicates that radiologists at nonacademic centers may be equally adept.35
Despite advances in CT imaging, substantial debate
persists surrounding the necessity of LP following a
negative head CT, particularly within the ﬁrst 6 hours
after onset of headache.93–97 While CSF can provide
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Figure 2. Continued.

crucial diagnostic information for alternative etiologies
of headache like meningitis, it remains an imperfect test
for SAH. Traumatic (blood-contaminated) LPs occur in
one of six cases.40 Xanthochromia takes many hours to
develop and is variably deﬁned. In addition, post-LP
headaches are common31,98 despite increasing use of
smaller-gauge, atraumatic spinal needles and reinserting the stylet before needle removal.32 Other potential

complications include low back pain, brainstem herniation, iatrogenic infection, epidural nerve injury, and
spinal hemorrhage.99,100 These factors combined with
patients’ negative bias against the procedure and the
physician time needed help explain emergency physicians’ reluctance to pursue LP despite a long-held belief
that this procedure was mandatory in the setting of suspected SAH.101–104 Our analysis provides new insight
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into the limited utility of performing LP to rule out SAH
after a negative CT. We found that, by incorporating
the risks and beneﬁts of both testing and continued
investigation into the decision analysis, the beneﬁts of
LP are unlikely to outweigh the harm across a wide
range of reasonable estimates of pretest disease prevalence and given the limited diagnostic accuracy of the
CSF analysis.
Brunell et al.34 noted that LP provided an alternative
diagnosis in 3% of suspected SAH cases, but only
altered subsequent management in 0.44% of individuals
who had an LP. This equates to 227 LPs (1/0.0044) to
identify one central nervous system infection requiring
antibiotics in suspected SAH patients. In addition, using
spectrophotometry, Brunell et al. noted ﬁve additional
cases of SAH representing 1.1% of LPs and a number

needed to LP (NNLP) of 91 (1/0.011) to identify one additional SAH. Of note, none of these additional cases of
“SAH” were aneurysmal, and none underwent subsequent surgery; thus the NNLP approaches inﬁnity for
detecting SAH that might beneﬁt from intervention.
Perry et al. reported 17/1546 false-negative CTs (with
postheadache onset imaging delays ranging from
8 hours to 8 days) that were identiﬁed by LP obtained
at the discretion of the attending emergency physician.20 However, only six of these individuals underwent
neurosurgical intervention (ventricular drain, aneurysm
coiling, or clipping), which equates to a NNLP = 258 (6/
1546 = 0.38%, 1/0.0038 = 258) to identify one aneurysm
amenable to neurosurgical intervention following a negative cranial CT. Sayer et al.36 reported NNLP = 250 to
identify one additional aneurysmal SAH. Blok et al.35

988

Carpenter et al. • SUBARACHNOID HEMORRHAGE EVIDENCE-BASED DIAGNOSTICS

Altered Mental Status

Figure 3. Forest plots for diagnostic elements of physical examination for SAH. LR = likelihood ratio; SAH = subarachnoid hemorrhage.

identiﬁed one perimesencephalic bleed among 760 CTnegative patients with suspected aneurysmal SAH,
which they extrapolated to NNLP = 15,200 to identify
one additional aneurysmal SAH given that one in 20
perimesencephalic bleeds are ultimately linked to an
aneurysm (760 9 20 = 15,200).105–107
Another approach to more deﬁnitively rule out SAH
after a nondiagnostic, noncontrast CT is to proceed to
CTA without an LP, an approach that 75% of patients
favored in one survey108,109 and supporting a role for
shared decision-making in evaluation of suspected

SAH.110 Some physicians have even advocated for predischarge CTA after a nondiagnostic CT and LP. Carstairs et al.17 examined CTA in addition to traditional
noncontrast CT. Patients who were CT negative and LP
negative underwent CTA to more deﬁnitively identify
either SAH or cerebral aneurysm. After evaluating 103
CT-negative/LP-negative patients, they detected two
cerebral aneurysms, which equates to a number needed
to CTA (NNCTA) = 52 to detect one cerebral aneurysm
that might or might not be the cause of the presenting
headache (2/103 = 1.9%, 1/0.019 = 52). Contemplating
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the NNCTA is essential because CTA is neither completely safe, nor always clinically meaningful. CTA complication rates range from 0.25% to 1.8%.111,112
Carstairs et al. interpreted the presence of cerebral
aneurysm by CTA to be equivalent to being disease positive for SAH, despite being unable to establish whether
the aneurysm was the etiology of the patient’s headache
or an incidental ﬁnding.
Indeed, intracranial saccular or berry aneurysms are
common, occurring in 1%–2% of the population.113
Linking a nonruptured aneurysm detected via CTA to

an individual patient’s headache is problematic. The discovery of an aneurysm in the context of headache is
often considered to be a symptomatic aneurysm, and
neurosurgical intervention may be advised depending
on aneurysm size, location, and speciﬁc patient characteristics.114 However, the relative risk of rupture for
cerebral aneurysms detected in symptomatic individuals
is eightfold higher than the rupture rate in asymptomatic individuals with incidentally noted cerebral
aneurysms.115 Based on one recent meta-analysis of 50
studies, the pooled sensitivity and speciﬁcity for CTA to
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Figure 3. continued.

detect aneurysms are 98 and 100%, respectively.44 MRA
can also be utilized to detect intracranial aneurysm, with
pooled sensitivity and speciﬁcity of 95 and 89%, respectively. Although MRA is more time-consuming and generally less available from the ED, it may be useful in
circumstances where radiation exposure is to be
avoided or a patient has an iodine contrast dye
allergy.45
Given the risks of overinvestigation and incidental
ﬁndings, it is important to scrutinize the testing thresholds for CT, LP, and angiography. We found that only

patients with a pre-CT likelihood of SAH well above
20% were likely to beneﬁt from an LP after a negative
unenhanced CT. Such pre-CT probabilities are exceptionally high and are far higher than the average diagnostic yield of around 5% for SAH on initial CT. The
limited ability of any feature on history or physical
examination to identify SAH also renders such high
pre-CT probabilities unlikely, except for severe cases
likely to have extensive bleeding visible on CT. Moreover, patients with only slightly higher pre-CT probabilities beneﬁt more from angiography than LP, given the
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Figure 4. Forest plots for diagnostic accuracy of CT for SAH. CT = computed tomography; LR = likelihood ratio; SAH = subarachnoid hemorrhage.

limitations of CSF analysis. Accordingly, this analysis
suggests that LP after a negative CT to “rule out” SAH
no longer seems rational for the large majority of
patients.
The utilitarian approach to decision-making test
thresholds is considered by some too arbitrary or artiﬁcial, yet it is critically important to recognize how to
apply these analyses at the bedside. The separation
between the test-positive and test-negative curves are a
visual representation of the diagnostic performance of
the test and thus illustrate the summary ﬁndings from
this meta-analysis. The vertical location of the horizontal
line that is used to calculate the test thresholds where it
intersects each curve is determined by the ratio

between beneﬁts and risks of further treatment and can
easily be shifted up or down to visually estimate new
thresholds on the graph. We used a 40:1 ratio of the
beneﬁts:risk of angiography, but allowed this to range
from 20:1 to 80:1 in a sensitivity analysis and obtained
similar ﬁndings. We extended this graphical approach
to include the nonzero risks of testing, as illustrated by
a narrowing of the range of pretest probabilities for
which the test is beneﬁcial. We selected a test:treatment
risk of 1:4 for CT and 1:2 for LP compared to angiography, but reduced the risk by half in another sensitivity
analysis with again similar ﬁndings.
Yet the most compelling argument in support of this
analysis is that the ﬁndings are strikingly similar to
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Figure 4. continued.

experienced clinicians’ own practice. Initial unenhanced
CT is rational across a wide range of pretest probabilities, as low as 1%. This 1 in 100 miss rate is consistent
with surveys of emergency physicians and a threshold
used in clinical decision rule construction for SAH and
other serious conditions.38,103 On the other hand, after a
negative CT, the low LR coupled with a low pre-CT
probability for SAH renders the post-CT probability so
low that the only moderately accurate LP is rarely warranted. As such, the observed practice of forgoing LP
after a negative CT, long considered to be a pitfall in
the management of these patients, is easily justiﬁed on
Bayesian grounds, as represented graphically on the
test indication curves.
The test indication curves also help clinicians avoid
the common fallacy sometimes invoked to persuade
headache patients that an LP is advisable. Many
explain a “95% sensitivity” of CT by counseling the
patient that “there is still a 1 in 20 (i.e., 100% –
95% = 5%) chance that you have a ruptured aneurysm.” This is only true if the patient were certain to
have a SAH prior to the test being ordered (pretest

probability = 100%). It is implausible that even the
most skilled clinician can predict SAH prior to any
testing in more than one in ﬁve awake and alert
patients, the very patient in whom an informed consent discussion is needed prior to LP. Our meta-analysis conﬁrms that there are few ﬁndings on history or
physical examination with a sufﬁciently strong association with SAH, and clinical decision rules suffer from
modest to poor speciﬁcity precisely because of this difﬁculty identifying disease positive patients prior to testing. Arguably, if one’s own diagnostic yield for SAH
on initial CT approaches 20% in awake headache
patients, one might expect one’s miss rate may be
unacceptably high. Moreover, such high-risk patients
beneﬁt from proceeding directly to CTA especially if
the unenhanced CT cannot be done within 6 hours of
headache onset, also as indicated on the test threshold
curves. On the other hand, using a more reasonable
pre-CT probability of 1 in 10 (still higher than the 7%
prevalence in prospective studies of emergency
patients with headache), a test with 95% sensitivity
and perfect speciﬁcity implies that the patient being
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Table 5
Diagnostic Accuracy of CSF Erythrocytes and Xanthochromia for SAH
Risk Factor

Sensitivity, % (95% CI)

CSF RBC > 1000
Czuczman 2013
65 (44–83)
Perry 2015
93 (68–100)
Pooled accuracy
76 (60–88)
Xanthochromia—U.K. NEQAS
Perry 2006
100 (16–100)
Gangloff 2015
100 (48–100)
Pooled accuracy
100 (59–100)
Xanthochromia—visual
Perry 2006
50 (1–99)
Dupont 2008
93 (66–100)
Gangloff 2015
80 (28–99)
Pooled accuracy
31 (21–41)
Xanthochromia—traditional
Perry 2006
100 (16–100)
Xanthochromia—Chalmers/Kiley
Perry 2006
0 (0–84)
Xanthochromia—Chalmers revised
Perry 2006
100 (16–100)

Specificity, % (95% CI)

LR+ (95% CI)

LR (95% CI)

79 (72–84)
91 (88–93)
88 (86–90)

3.09 (2.09–4.57)
10.25 (7.73–13.59)
5.66 (1.38–23.27)

0.44 (0.26–0.75)
0.07 (0.01–0.49)
0.21 (0.03–1.66)

83 (77–88)
98 (97–99)
95 (93–96)

4.87 (2.71–8.73)
47.67 (26.67–85.20)
15.23 (1.58–146.73)

0.20 (0.02–2.53)
0.08 (0.01–1.21)
0.13 (0.02–0.83)

97
95
99
98

15.57
19.13
62.31
28.79

0.52
0.08
0.20
0.22

(93–99)
(89–98)
(98–99)
(97–99)

(3.25–74.54)
(8.04–45.45)
(28.47–136.37)
(9.77–84.80)

(0.13–2.07)
(0.01–0.50)
(0.04–1.17)
(0.06–0.80)

29 (23–35)

1.17 (0.70–1.96)

0.57 (0.05–7.28)

89 (84–93)

1.49 (0.12–19.23)

0.94 (0.56–1.56)

29 (23–35)

1.17 (0.70–1.96)

0.57 (0.05–7.28)

CSF = cerebrospinal fluid; LR+ = positive likelihood ratio; LR = negative likelihood ratio; NEQAS = National External Quality
Assessment Service; RBCs = red blood cells; SAH = subarachnoid hemorrhage.
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Figure 5. Forest plots for diagnostic accuracy of CSF analysis for SAH. CSF = cerebrospinal fluid; LR = likelihood ratio; SAH = subarachnoid hemorrhage.

counseled actually has only a 1 in 180 chance of a ruptured aneurysm (posttest odds = pre-test odds 9
LR = 1:9 9 0.05).
A cost-effectiveness analysis comparing CT-only, CT/
CTA, CT/LP, and CT/MRA as diagnostic modalities
found that CT-only and CT/LP are the preferred strategies of diagnosing ED patients with suspected SAH.116
The CT/LP strategy was slightly more costly, but more
effective due to the LP reducing the possibility of a
missed diagnosis and subsequent harm. However, since

the results of this meta-analysis indicate a much lower
threshold for LP than used in the sensitivity analyses of
the cost-effectiveness analysis, an updated cost-effectiveness analysis would likely shift the preference
toward a CT-only strategy by decreasing the effectiveness of the CT/LP strategy. Further, this cost-effectiveness analysis did not consider crowding in the ED or
physician and patient reluctance toward LP, which are
practical barriers to the implementation of a CT/LP
strategy.
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Implications for Future Research
LP has long been considered to be the criterion standard for diagnosing SAH as it may detect small
amounts of xanthochromia or blood in the CSF missed
by CT. Due to the advancement of multislice CT, sensitivity to detect SAH has increased substantially. The primary clinical question for emergency physicians
remains whether LP is indicated to rule out SAH if head
CT is negative. Recent literature suggests within
6 hours of symptom onset sensitivity of CT approaches
100%. Additional studies in heterogeneous settings (rural, non-North American, community hospitals) are
needed to conﬁrm this diagnostic accuracy.
The signiﬁcant interstudy heterogeneity observed in
our meta-analysis indicates that more research is needed
to quantify the diagnostic accuracy of history and physical examination, as well as visible or spectrophotometric
assessment of xanthochromia for the diagnosis of SAH.
Unfortunately, few SAH studies adhere to the Standards
for Reporting of Diagnostic Accuracy (STARD) reporting

guidelines.117 Failure to use reporting standards makes
diagnostic studies more difﬁcult for clinicians, researchers, and guideline developers to locate, interpret, and
compare.118 This is reﬂected in the poor inter-rater reliability results observed in our QUADAS-2 assessments of
blinding and appropriately reproducible conduct of the
index tests. In addition, studies that do not use the
STARD criteria are less likely to report key details necessary for clinicians to understand the risk of bias and
expected skew of observed point estimates. Future diagnostic studies should adhere to the STARD reporting
standards117 and history/physical examination studies
should follow the STARD criteria recommended for such
studies.119
Spectrophotometric assessment of xanthochromia
should be standardized in terms of conduct and
reporting.78 Most studies did not obtain an LP in all
patients or report any standard follow-up protocol to
capture false-negatives. Opening pressures were only
obtained in 2% of suspected SAH cases34 and no
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studies evaluated the diagnostic accuracy of opening
pressures. Future studies reporting the diagnostic
accuracy of CT should uniformly report the resolution
and timing of imaging, while incorporating post-ED
follow-up at reasonable intervals including review of
death registries for detection of false-negative results.
In addition, the volume of CSF blood and rapidity of
aneurysmal bleeding probably inﬂuence both CT and
LP test accuracy, threatening test independence implicit
in Bayesian analyses, and therefore merits assessment

for interactions. Future diagnostic researchers should
also evaluate test performance stratiﬁed by age since
aneurysmal SAH are rare in young patients. Furthermore, the skew of observed sensitivities and speciﬁcities as a result of spectrum bias, partial veriﬁcation
bias, differential veriﬁcation bias, and imperfect criterion standard bias should be contemplated in future
studies.51
A planned secondary outcome of this systematic
review was to examine clinically signiﬁcant SAH cases,
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Figure 6. Bernstein test indication curves for CT and LP. Test indication curves with 95% CI natural scale in A–D. Diagnostic accuracy of CT or lumbar puncture for SAH. Raw test indication curves as proposed by Bernstein are shown, providing a graphical representation of the Bayesian posttest probability (y-axis) based on either a positive (upper curved black line, with 95% CIs in gray) or
a negative (lower curved lines) test result as a function of the pretest probability (x-axis). The graphs use the same principle as the
Fagan nomogram, but provide more intuitive representations of the diagnostic accuracy of a test. The four tests considered are cranial CT obtained within 6 hours (A) or later (B) from headache onset or LP with more than 1,000 9 106/L RBCs (C) or visible xanthochromia (D). The distances of the curves from the main diagonal of zero diagnostic information provide a visual representation
of the information gained from the test result. CT = computed tomography; LP = lumbar puncture; SAH = subarachnoid hemorrhage; RBCs = red blood cells.

deﬁned as requiring neurosurgical intervention. The
studies in this systematic review did not report adequately to be able to assess these outcomes. Speciﬁcally,
perimesencephalic hemorrhage is traditionally considered to be “true-positive” in SAH diagnostic research,
but has a benign clinical course without speciﬁc
interventions to alter the natural course of disease
other than analgesic symptom control. However,

perimesencephalic SAH can recur120 and some neurosurgeons recommend catheter angiography in suspected SAH patients with xanthochromia after a
nondiagnostic CTA since a culprit aneurysm will be
identiﬁed in 8.3% of these cases.121 In clinical practice
SAH is deemed perimesencephalic if two-catheter
angiography studies 7 days apart demonstrate no cerebral aneurysm, since a single-catheter angiogram and
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C LP Using RBC Counts in the Final Tube

D LP Using Visible Xanthochromia

Figure 7. Testing thresholds. Test indication curves illustrating when benefits of testing outweigh the risks for SAH. The complete
test indication curves as proposed by Bernstein are shown which incorporate the Pauker-Kassirer threshold approach to deciding
whether to perform the test in question. This technique compares the risks versus benefits for treatment (in this case proceeding to
CT or formal angiography) and calculates the corresponding treatment threshold (shown as horizontal dashed lines, with the point
estimate in black and the upper and lower bands of the sensitivity analysis in gray). The vertical dashed line (or rightmost line
when two are visible) therefore represents the pretest probability range below which the diagnostic test might be appropriate,
assuming that the test in question had neither risks nor costs; when the pretest probability is higher, empirical treatment is recommended since the posttest probability exceeds this threshold even if the test is negative. Because tests have a nonzero risk, the
actual pretest range for which performing the test is rational is narrower and is shown by the thick line between the arrowheads.
The thinner solid line extending beyond the arrows illustrates the effect of reducing the test risk by half. At pretest probabilities to
the left of this range, no further testing is indicated. For example, this approach suggests proceeding directly to angiography when
the pre-CT probability exceeds 10% (B), unless the unenhanced CT can be obtained within 6 hours (A) in which case a pretest probability of nearly 70% seems appropriate before proceeding directly to angiography. On the other hand, the use of CT is warranted
even in very-low-risk patients, down to perhaps 0.7% pretest probability as determined primarily by the risks of the CT itself. The
LP curves, however, illustrate that the pre-LP probabilities that justify performing LP are very narrow, ranging from 2% to 4% in C
and 2% to 7% in D. Moreover, these pre-LP probabilities in turn can only arise after an implausibly high pre-CT probability (>>20%).
CT = computed tomography; LP = lumbar puncture; SAH = subarachnoid hemorrhage; RBCs = red blood cells.

CTA can miss 4.2% of aneurysms.122 None of the diagnostic studies included in this meta-analysis reported
uniform CT or catheter angiograms in all patients,

let alone repeat catheter angiograms in those with initially “negative” or nondiagnostic advanced imaging.
Future studies examining SAH should distinguish
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Table 6
Using Test Indication Curves
You have just seen a 48-year-old housewife who presents
to the ED by private vehicle 8 hours after the onset of a
severe headache that peaked within 10 minutes of onset.
She is nauseated and complains of neck stiffness but her
neurologic examination is intact and she is able to fully
flex her neck. You assign a pretest probability of 10% for
SAH and await the final read by the neuroradiologist on
duty even though the imaging study appears to be
unremarkable to you and to the CT technician. The test–
treatment curves can be used like the Fagan nomogram to
calculate the posttest probability of disease. Therefore, you
can estimate that the posttest probability will be around
0.8% should the study prove negative (Figure 7B). You can
also estimate that, if you had performed an LP rather than
CT, the posttest likelihood would be around 2% if fewer
than 1,000 9 106/L RBCs were present in the final tube of
CSF (Figure 7C), and similarly 2% if there were no visible
xanthochromia. But you can also “chain” sequential test
results, with the usual caveat that the tests may not be
perfectly independent. Thus, after the neuroradiologist
confirms that there are no signs of SAH on the CT, the
same patient would have her probability of disease
lowered from 0.8% pre-LP to about 0.1% after an LP
negative for xanthochromia (Figure 7D). Moreover,
decision analysis would suggest that, for this patient, the
risks of LP outweigh the potential benefits, since the
pretest probability of 0.8% is already below the range
when LP is beneficial whether one uses erythrocyte count
or xanthochromia, as indicated by the horizontal arrows on
the test indication curves.

aneurysmal SAH from perimesencephalic hemorrhage
to better examine SAH that merits surgical intervention.
LIMITATIONS
Identiﬁcation of studies for this meta-analysis used only
one individual with adjudication of uncertainty of inclusion/exclusion criteria by a second author, which could
introduce a bias in study selection. In addition, we
excluded non-English studies which could have limited
the scope of our ﬁndings and yield biased summary
estimates, although review of interventional meta-analyses do not suggest signiﬁcant differences when nonEnglish studies are excluded.123 Of the 22 studies that
provided sufﬁcient detail to be able to reconstruct 2 9 2
tables, there was signiﬁcant heterogeneity in the manner in which data were collected and reported. For
example, when examining sensitivity and speciﬁcity of
noncontrast head CT, not all studies reported the speciﬁc technology utilized. When technology utilized was
reported, it was done so in an inconsistent manner
making it unclear which generation (how many slice)
CT scanner was used. Variation in technology undoubtedly affects diagnostic test performance, and standardized reporting of the particular technology used should
be encouraged in all future studies.117
Signiﬁcant variation existed in mechanisms of followup for patients that were deemed SAH-negative. Some
studies did not conduct any follow-up, while others had
structured telephone questionnaires and examined
coroner records and public death certiﬁcates to ensure
that patients deemed disease free did not later turn out
to have SAH. Without follow-up for patients that were
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deemed SAH negative it is impossible to know that the
patient truly did not have a small CT-undetectable SAH
or cerebral aneurysm when they were discharged from
the ED. Finally, because some of the studies included
patients who were unconscious or had neurologic deﬁcits, the observed estimates of sensitivity and speciﬁcity
may be inﬂuenced by the spectrum of disease severity.53
There was also signiﬁcant variation in deﬁnition of
disease, particularly in the incorporation of CSF ﬁndings into the deﬁnition of being SAH-positive. Deﬁnition
of disease-positive ranged from number of RBCs in the
ﬁnal tube via LP to xanthochromia of CSF. Number of
RBCs was not standardized. Xanthochromia was
deﬁned by visual inspection in some studies and spectrophotometry in others. Xanthochromia via spectrophotometry had substantial variation in the
absorption spectrum used to deﬁne a positive LP. Other
studies used spectrophotometry to detect bilirubin and
oxyhemoglobin as indicating a patient with SAH.
CONCLUSIONS
This meta-analysis identiﬁed a 7.5% weighted prevalence of subarachnoid hemorrhage in ED patients with
concerning headache. Although the available high-quality diagnostic evidence is limited, there is no single
characteristic on history or physical examination that is
adequate to rule in or rule out subarachnoid hemorrhage in ED settings. Using a threshold of 1,000 9 106/L
red blood cells in the ﬁnal tube has a summary positive
likelihood ratio of 5.7 and negative likelihood ratio of
0.21. Within 6 hours of symptom onset, noncontrast
cranial computed tomography accurately both rules in
and rules out subarachnoid hemorrhage. Given the
risks and beneﬁts of further testing and the limited
diagnostic accuracy of cerebrospinal ﬂuid erythrocyte
counts and of various xanthochromia deﬁnitions, lumbar puncture is likely to beneﬁt only patients within a
narrow band of pre–lumbar puncture probabilities,
around 2% to 7%. Given the accuracy of computed
tomography, even several hours after headache onset,
such pre–lumbar puncture probabilities correspond to
pre–computed tomography probabilities of 20% or
higher. While many still consider computed tomography followed by lumbar puncture to be the criterion
standard for the diagnosis of subarachnoid hemorrhage, few studies use this criterion standard given
practice patterns evolving away from routine lumbar
puncture. The role of lumbar puncture may well wane
further with improving multislice computed tomography and increasing evidence to refute the utility of lumbar puncture. Validation of subarachnoid hemorrhage
clinical decision rules offers the opportunity to more
accurately risk stratify ED headache patients to identify
subsets most likely to beneﬁt from post–computed
tomography lumbar puncture, computed tomography
angiography, or no further testing.
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